Human Amniotic-Derived Mesenchymal Stem Cells
Calciphylaxis
The First Affiliated Hospital with Nanjing Medical UniversityCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Calciphylaxis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Oxygen Jay C. Buckey Jr. | Phase 4 | BB |
hexasodium fytate Sanifit Therapeutics S. A. | Phase 2 | B |
Sodium Thiosulfate Centre Hospitalier St Esprit | D |
Same molecule, other indications
Human Amniotic-Derived Mesenchymal Stem Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →